Some scientists see a challenge and step back. Others, like Shehaab Savliwala, see a challenge and lean in – armed with a pipette, a plan, and an uncanny ability to turn “impossible” into “achieved.” At Singota Solutions, where precision and innovation are non-negotiable, Shehaab has earned the nickname “Dr. Impossible” for his fearless approach to tackling the toughest Injectable formulation puzzles. Whether it’s optimizing nanoparticle formulations, ensuring in-use stability, or overcoming solubility nightmares, he thrives where others hesitate.
But how does someone become a problem-solving powerhouse in pharmaceutical formulation? For Shehaab, the journey began in Maharashtra, India, where a love for chemical engineering and nanomedicine led to groundbreaking research, a prestigious patent, and over 800 citations across peer-reviewed publications. His career has been built on curiosity, persistence, and an ability to see beyond the limits of conventional formulation science.
Now, as a senior formulation scientist at Singota (Bloomington, Indiana CDMO specializing in injectable formulation development, analytical method and drug development, aseptic filling, and supply chain management), Shehaab brings that same drive and expertise to early-phase drug development—helping clients navigate the complexities of small-batch injectable formulation with precision, ingenuity, and a deep commitment to scientific excellence. His work is about more than just problem-solving—it’s about engineering solutions that move life-saving therapies forward.
Shehaab’s approach is rooted in the belief that every formulation challenge is an opportunity to innovate. Whether it’s developing a method to stabilize a notoriously unstable compound or customizing a formulation to enhance bioavailability, he thrives on the complexity that comes with early-phase drug development. His ability to bridge scientific theory with practical application makes him an invaluable resource for clients facing unique formulation hurdles.
So, what does it take to transform complex formulation challenges into clinical success? Let’s dive into Dr. Impossible’s journey, the breakthroughs he’s led, and how his expertise is shaping the future of injectable drug development at Singota Solutions.